Ledger.Open graph →
SEC Form D · Amendment · filed August 22, 2016

Amylyx Pharmaceuticals, Inc

Offering
$5.0M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Peter B. Finn · Boston, MAExecJoshua Cohen · Cambridge, MAExec · DirectorGeorge Milne · Cambridge, MADirectorStephen D. Chubb · Cambridge, MADirectorJustin Klee · Cambridge, MAExec · DirectorJames F. Kellogg Iii · Boston, MADirectorJonathan J. Desimone · Boston, MAExec · DirectorNolan Chicoine · Calgary, Alberta, CanadaDirectorChristopher F. Linneman · Boston, MAExec · DirectorEric M. Siegal · CHICAGO, ILExecDaniel M. Rosenbloom · CHICAGO, ILExecMikhail Plam · Louisville, CODirectorDavid C. Barker · Louisville, COExec · DirectorNiles C. Utlaut · Louisville, COExec · DirectorCorporate Director Gpe Viii Investments Manager Limited · Nicosia, G4Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗